The DOI matches its Crossref record; 87 of the 88 references it cites were found in a registry or an index.
Epidemiology as a Guide to Clinical Decisions: The Association between Triglyceride and Coronary Heart Disease
Abstract
The hypothesis that triglyceride is a cause of coronary heart disease, although unconfirmed and never universally accepted, has nonetheless strongly influenced the practice of preventive medicine. We have examined the epidemiologic association between triglyceride and coronary heart disease to evaluate the validity of inferring that there is a causal relation between the two. Neither the evidence from published studies nor an analysis of data from the Western Collaborative Group Study provides strong support for the causal hypothesis. Information from other scientific disciplines is also meager, contrasting with the coherence of diverse evidence supporting the hypothesis that cholesterol is a cause of coronary heart disease. These arguments fall short of disproving the belief that lowering triglyceride will prevent coronary heart disease, especially since triglyceride and cholesterol are inextricably associated through mutual lipoprotein carriers. But we propose that the ethics of preventive medicine place the burden of proof on the proponents of intervention. We therefore recommend that widespread screening and treatment of healthy persons for hypertriglyceridemia be abandoned until more persuasive evidence becomes available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“observational studies and clinical trials 3,232,367,374 -380 that have consistently demonstrated the lowest risk of incident and recurrent CVD in association with the lowest fasting triglyceride levels.”
From Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association (2011) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.
Kannel, W., Castelli, W., Gordon, T., & McNamara, P. M. (2020) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-1-1 · Cited by 2,160
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701052760107 · Cited by 1,911
Clofibrate and Niacin in Coronary Heart Disease
Stamler, J. (1975) · JAMA · doi:10.1001/jama.1975.03240160024021 · Cited by 1,750
Castelli, W. P., Doyle, J. T., Gordon, T., Hames, C. G., Hjortland, M. C., Hulley, S. B., Kagan, A., & Zukel, W. J. (1977) · Circulation · doi:10.1161/01.cir.55.5.767 · Cited by 1,492
Self-citationCholesterol in the Prediction of Atherosclerotic Disease
Kannel, W. B., Castelli, W. P., & Gordon, T. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-90-1-85 · Cited by 1,314
Coronary Heart Disease in the Western Collaborative Group Study
Rosenman, R. H. (1975) · JAMA · doi:10.1001/jama.233.8.872 · Cited by 1,274
Self-citationOliver, M., Heady, J., Morris, J. N., Cooper, J., Geizerova, H., Gyárfás, I., Green, K., Strasser, T., Macfie, W. G., Scott, E., et al. (1978) · Heart · doi:10.1136/hrt.40.10.1069 · Cited by 1,047
Reisin, E., Abel, R., Modan, M., Silverberg, D. S., Eliahou, H. E., & Modan, B. (1978) · New England Journal of Medicine · doi:10.1056/nejm197801052980101 · Cited by 759
ISCHÆMIC HEART-DISEASE IN RELATION TO FASTING VALUES OF PLASMA TRIGLYCERIDES AND CHOLESTEROL
Carlson, L., & Böttiger, L. E. (1972) · The Lancet · doi:10.1016/s0140-6736(72)90738-6 · Cited by 752
Hyperlipidemia in Coronary Heart Disease I. LIPID LEVELS IN 500 SURVIVORS OF MYOCARDIAL INFARCTION
Goldstein, J. L., Hazzard, W. R., Schrott, H. G., Bierman, E. L., & Motulsky, A. G. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107331 · Cited by 621
Research works printed but not linked: 11
- Hayes, 1964, Clin Sci, 26, 185
- Rhoads, 1978, Lab Invest, 38, 304
- Bierman EL. Atherosclerosis and other forms of arteriosclerosis. In: Isselbacher KJ, Adams RD, Braunwald E, Petersdorf RG, Wilson JD, eds. Harrison's principles of internal medicine. 9th edition. New York: McGraw-Hill, 1980:1156–66.
- Cornfield, 1959, Am J Ment Defic, 64, 240
- Grundy, 1978, West J Med, 128, 13
- McGill HC. Atherosclerosis: problems in pathogenesis. In: Paoletti R, Gotto AM, eds. Atherosclerosis Reviews. Vol. 2. New York: Raven Press, 1977; 2:27–65.
- Vil, 1978, N Engl J Med, 298, 109
- 10.1001/jama.231.4.360 · DOI
- McKeown T. Unvalidated procedures have no place in screening programs. In: Ingelfinger FJ, Ebert RV, Finland M, Relman AS, eds. Controversies in internal medicine II. Philadelphia: WB Saunders, 1974:92–8.
- University Group Diabetes Program, 1970, Diabetes, 19, 785
- University Group Diabetes Program, 1975, Diabetes, 24, 65
Cited by
Sorted by citations
Items 501–600 of 701
Lipoproteins as risk factors for coronary heart disease.
Eder, H. A. (1982) · PubMed Central · Cited by 6
The Lipid Hypothesis and the Seven Countries Study
Lordan, R., Τσούπρας, Α., & Zabetakis, I. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813792-5.00004-5 · Cited by 5
Tosin, J. O., Obianime, A. W., Iyeopu, S. M., Simeon, J. O., Chinwe, A., & Musa, T. L. (2019) · European Scientific Journal ESJ · doi:10.19044/esj.2019.v15n21p280 · Cited by 6
Linton, J. A., Kimm, H., Ohrr, H., Park, I. S., & Jee, S. H. (2009) · Circulation Journal · doi:10.1253/circj.cj-08-0936 · Cited by 5
Simons, L. A., England, J. D. F., Balasubramaniam, S., & Viles, L. (1982) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1982.tb02648.x · Cited by 5
Epidemiology, Risk Factors, and Pathophysiology of Ischemic Heart Disease
Blessey, R. L. (1985) · Physical Therapy · doi:10.1093/ptj/65.12.1796 · Cited by 5
Progestogens: Symptomatic and Metabolic Side Effects
Montgomery, J. C., & Crook, D. (1990) · Springer eBooks · doi:10.1007/978-1-4471-1799-5_16 · Cited by 5
Fish Oils - Their Significance to Human Health
Rice, R. (1988) · Journal of the Royal Society of Medicine · doi:10.1177/014107688808100902 · Cited by 5
Prevalence of familial hypertriglyceridemia: The Princeton School District Family Study
Laskarzewski, P. M., Khoury, P. R., Kelly, K. A., Mellies, M. J., Morrison, J. A., & Glueck, C. J. (1982) · Preventive Medicine · doi:10.1016/0091-7435(82)90057-3 · Cited by 5
¿Cuántos pacientes precisan tratamiento para la hipercolesteremia?
Arnáiz, C. S., Navarro, L. M., Torguet, A. V., Eguíluz, E. G., Lluch, M. P., & Ortega, M. (2000) · Atención Primaria · doi:10.1016/s0212-6567(00)78529-5 · Cited by 5
Role of the Clinical Biochemistry Laboratory in the Assessment of Dyslipoproteinaemias
Ballantyne, F. C. (1984) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456328402100302 · Cited by 5
Wirkung von Bezafibrat bei primären Hyperlipidämien
Wechsler, J. G., Hutt, V., Klör, H. U., Bode, G., & Ditschuneit, H. H. M. (1982) · Journal of Molecular Medicine · doi:10.1007/bf01716387 · Cited by 5
Triglyceride Measurement and Its Relationship to Heart Disease
Stein, E. A., & Steiner, P. M. (1989) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30648-6 · Cited by 5
Antherosclerosis and hyperlipidaemia: Genetic polymorphism and plasma lipoproteins
Thompson, G. R., & Soutar, A. K. (1983) · Nature · doi:10.1038/301658a0 · Cited by 5
Mohan, V., Deepa, R., Rani, S. S., & Premalatha, G. (2001) · Cited by 4
Recent Advances in the Synthesis and Analysis of Atorvastatin and its Intermediates
Li, S., Zhang, W., Zhang, W., Huang, A., Zhu, J., Wang, Y., & Zheng, Y. (2023) · Current Medicinal Chemistry · doi:10.2174/0109298673263728231004053704 · Cited by 4
Study on lipid and glucose metabolism in patients with vasospastic angina.
Yoshida, H., MURAKAMI, K., & Mimura, G. (1989) · Japanese Journal of Medicine · doi:10.2169/internalmedicine1962.28.348 · Cited by 4
Relationships between triglycerides, lipoproteins, glucose and coronary artery disease
Hobbs, G. A., Wagner, S. G., & Levinson, S. S. (1995) · Clinica Chimica Acta · doi:10.1016/0009-8981(95)06076-p · Cited by 4
Tzanatos, H. A., Koutsikos, D. K., Agroyannis, B. J., Kapetanaki, A., Tsoutsos, D., Konstadinidou, I. K., Chondros, K. P., & Exarchos, D. (1994) · Renal Failure · doi:10.3109/08860229409044879 · Cited by 4
Epidemiology and pathogenesis of hypertension in people with diabetes mellitus
(2003) · CRC Press eBooks · doi:10.3109/9780203624357-3 · Cited by 4
Sommariva, D., Tirrito, M. L., Bellintani, L., Bonfiglioli, D., Branchi, A., Pogliaghi, I., & Ottomano, C. (1986) · La Ricerca in Clinica e in Laboratorio · doi:10.1007/bf02886744 · Cited by 4
Mirani‐Oostdijk, C. P., van Gent, C. M., Terpstra, J., Hessel, L. W., & Frölich, M. A. (1981) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1981.tb09815.x · Cited by 4
Renal insufficiency, mortality and myocardial infarction
Holzmann, M. J. (2008) · Figshare · Cited by 4
Zarama, M., & Raij, L. R. (1993) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(93)70101-4 · Cited by 4
The Role of Non-High-Density Lipoprotein-Cholesterol in Evaluation and Treatment of Lipid Disorders
Havel, R. J., & Frost, P. H. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.6.2105 · Cited by 4
Endogenous hypertriglyceridemia in a nonobese rat model: Plasma lipoproteins and dietary sensitivity
Lovati, M. R., Franceschini, G., Allievi, L., Dall’Aglio, E., Zavaroni, I., & Sirtori, C. R. (1986) · Metabolism · doi:10.1016/0026-0495(86)90134-4 · Cited by 4
Sommariva, D., Tirrito, M. L., Bonfiglioli, D., Pogliaghi, I., Cabrini, E., Bellintani, L., & Fasoli, A. (1985) · Atherosclerosis · doi:10.1016/0021-9150(85)90089-9 · Cited by 4
Current controversies in nutrition
Kien, C. L. (1990) · Current Problems in Pediatrics · doi:10.1016/0045-9380(90)90035-y · Cited by 4
Individualized Diets for Diabetic Patients
Nuttall, F. Q., MARYNIUK, M. D., & KAUFMAN, M. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-2-204 · Cited by 4
Editorial note Coronary artery disease: raised cholesterol or triglycerides?
Riemersma, R. A. (1984) · International Journal of Cardiology · doi:10.1016/0167-5273(84)90144-x · Cited by 4
Leng, G. C., & Fowkes, F. G. R. (1991) · Springer eBooks · doi:10.1007/978-1-4471-1889-3_14 · Cited by 4
Verma, R. C., Pant, K. K., Amod, K. S., Nath, R., Rakesh, K. D., & Shailendra, D. (2013) · doi:10.6084/m9.figshare.661603.v1 · Cited by 3
An infant with hypertriglyceridemia presenting as failure to thrive: a case report
Srinivas, R. K., Gupta, A., Mathur, P., Agarwal, K. K., & Sharma, A. K. (2021) · International Journal of Contemporary Pediatrics · doi:10.18203/2349-3291.ijcp20210673 · Cited by 3
Changes in serum lipids in normal and diabetic guinea pigs on feeding Phaseolus aureus (Green gram)
Srivastava, A., Joshi, L. D., & Singh, S. (1989) · Indian Journal of Clinical Biochemistry · doi:10.1007/bf02867652 · Cited by 3
Oster, P., Lang, P. D., Vollmar, J. F., & Schlierf, G. (1986) · Research in Experimental Medicine · doi:10.1007/bf01852196 · Cited by 3
Endrikat, J., Lange, E., Kunz, M., Schmidt, W., & Gräser, T. (2007) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625180701441030 · Cited by 3
Alaupovic, P. (2002) · Oléagineux Corps gras Lipides · doi:10.1051/ocl.2002.0220 · Cited by 3
[Physical activity in adolescence].
Tanaka, K., & Nakata, Y. (2000) · PubMed · Cited by 3
Study of lipid profile in acute myocardial infarction within 24 hours
Kumar, P., Singh, S., Prasad, S., Yadav, U. P., & Agrawal, P. K. (2018) · Annals of Applied Bio-Sciences · doi:10.21276/aabs.1677 · Cited by 3
Zhao, C., Ji, M., Zhang, J., Jia, Q., Liu, J.-Y., An, F., Chen, Z., Li, L., Wang, L., Ma, W., et al. (2018) · Bioscience Reports · doi:10.1042/bsr20181502 · Cited by 3
Elevation of Serum Triglyceride Levels from Oral 13-cis-Retinoic Acid
Nigra, T. P., Katz, R. A., & Jorgensen, H. (1981) · Springer eBooks · doi:10.1007/978-3-642-68023-6_52 · Cited by 3
Epidemiologie der Risikofaktoren
Nüssel, E., Buchholz, L., & Morgenstern, W. (1984) · Springer eBooks · doi:10.1007/978-3-642-69451-6_5 · Cited by 2
Exercise, Hormone Therapy, and Lipoproteins in Women
Grady, D. G. (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb00926.x · Cited by 3
Sex Difference in Risk Factors of Lipid Metabolism for Coronary Artery Disease.
Tamuğur, E., Özer, M., Güner, G., & Djavani, M. M. (1992) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.13.63 · Cited by 3
Cradle-to-grave atherosclerosis: high density lipoprotein cholesterol.
Glueck, C. J. (1982) · Journal of the American College of Nutrition · doi:10.1080/07315724.1982.10718092 · Cited by 3
Borderline hypercholesterolaemia: when to introduce drugs
Bhatnagar, D., & Durrington, P. N. (1989) · Postgraduate Medical Journal · doi:10.1136/pgmj.65.766.543 · Cited by 3
Pathogenesis of Hypertriglyceridemia: Implications for Coronary Heart Disease and Therapy
Vega, G. L., & Grundy, S. M. (1988) · Advances in experimental medicine and biology · doi:10.1007/978-1-4613-0733-4_39 · Cited by 3
Spending some of the preregistration year in general practice [.
Hull, F. M. (1989) · BMJ · doi:10.1136/bmj.298.6671.406 · Cited by 3
THE NICKEL(I) CATALYZED COUPLING OF A DIARYLZINC WITH AN ARYL CHLORIDE IN THE SYNTHESIS OF XENALIPIN
Eaddy, J. F. (1995) · Organic Preparations and Procedures International · doi:10.1080/00304949509458470 · Cited by 3
Medical Student Response to a Class Lipid-Screening Project
Lum, G., Weinstein, J., & Carter, A. C. (1982) · Journal of American College Health · doi:10.1080/07448481.1982.10392798 · Cited by 3
Effect of variation in diet on lipoprotein metabolism in patients with diabetes mellitus
Hollenbeck, C. B., & Coulston, A. M. (1987) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610030304 · Cited by 3
CONTROL OF LIPID DISORDERS IN PATIENTS WITH ATHEROSCLEROTIC VASCULAR DISEASE
Marks, A. D. (1998) · Surgical Clinics of North America · doi:10.1016/s0039-6109(05)70324-8 · Cited by 3
Single Nucleotide Variances Can Account for Loss of microRNA Function
Li, R., & Guo, J. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.04.045 · Cited by 3
Cardiac and Pulmonary Diseases: Nutritional Implications
McCauley, K. M., & Weaver, T. E. (1983) · Nursing Clinics of North America · doi:10.1016/s0029-6465(22)01705-4 · Cited by 3
Thompson, G. R. (1985) · Elsevier eBooks · doi:10.1016/b978-0-407-02312-3.50014-4 · Cited by 3
Marniemi, J., Maatela, J., Järvisalo, J. O., Reunanen, A., Mäki, J., & Tikkanen, M. J. (1994) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519409086508 · Cited by 3
The Reversibility of Obesity, Diabetes, Hyperlipidemia, and Coronary Heart Disease
Anderson, J. W., & Akanji, A. O. (1994) · Humana Press eBooks · doi:10.1007/978-1-4684-8136-5_10 · Cited by 3
Lipid Metabolism in Chronic Renal Failure
Drukker, A. (1981) · Springer eBooks · doi:10.1007/978-94-009-8319-9_41 · Cited by 3
Preventive medicine in practice: the state of the art.
Maron, D. J. (1981) · PubMed Central · Cited by 3
Hipertrigliceridemia (> 150 mg/dl) como marcador de riesgo cardiovascular
López-Miranda, J. (2025) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2025.500822 · Cited by 2
Maternal High Fat Diet and its Expressions in the Heart and Liver in the Mice Embryogenesis
Nirala, S., Tan, X., Shafiq, M., Basnet, R., & Singh, A. (2023) · Current Molecular Medicine · doi:10.2174/1566524023666230605142119 · Cited by 2
Epidemiology, Control, and Cardiovascular Outcomes of Dyslipidemia in Diabetes
Fan, W., & Wong, N. D. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-26681-2_32 · Cited by 2
Lipoproteins and Cardiovascular Disease Risk
Dhingra, R., & Vasan, R. S. (2015) · Contemporary Endocrinology · doi:10.1007/978-1-60761-424-1_4 · Cited by 2
Flow cytometric quantification of cholesteryl ester-containing “foam” cells
Cupp, J. E., Khan, M. A., Campbell, G., Henderson, G. R., & Kruth, H. S. (1987) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(87)90030-x · Cited by 2
Pfeuffer, M., Hagemeister, H., & Barth, C. A. (1988) · Zeitschrift für Ernährungswissenschaft · doi:10.1007/bf02019509 · Cited by 2
Al‐Muhtaseb, N., & Al-Yousuf, A. R. (1992) · Annals of Saudi Medicine · doi:10.5144/0256-4947.1992.252 · Cited by 2
Frequency of metabolic syndrome components in patients with ischemic heart disease
Pećanac, Ž., Stanetić, K., & Šormaz, L. (2018) · Биомедицинска истраживања · doi:10.7251/bii1801016p · Cited by 2
Citkowitz, E., & Herbert, P. N. (1999) · Developments in cardiovascular medicine · doi:10.1007/978-1-4615-5007-5_3 · Cited by 2
Epidemiology and pathogenesis of hypertension in people with diabetes mellitus
Williams, B. (2003) · CRC Press eBooks · doi:10.3109/9780203624357-6 · Cited by 2
Plasma Apolipoproteins and Lipids in Normal Persons and Patients with Hypertension
Lee, S. S., Jhoo, Y. M., Oh, D. J., Lee, M. H., Chung, E. S., & Lee, S. J. (1986) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.1986.1.2.214 · Cited by 2
HDL cholesterol and triglycerides as risk factors for CHD
Wilson, P. W. F., & Anderson, K. M. (1990) · Springer eBooks · doi:10.1007/978-94-009-0731-7_78 · Cited by 2
Vogel, F., & Motulsky, A. G. (1986) · Springer eBooks · doi:10.1007/978-3-662-02489-8_4 · Cited by 2
Synthesis of carbon‐14 labelled xenalipin ‐ a potential hypolipidemic agent
Hill, J. A., & Eaddy, J. F. (1992) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.2580311208 · Cited by 2
Leon, A. S., Hunninghake, D. B., Belcher, J., & Stoulil, J. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90127-7 · Cited by 2
Receptor‐mediated uptake of hypertriglyceridaemic VLDL remnants by mouse macrophages in vitro
Naruszewicz, M., & Szostak, W. B. (1985) · Food / Nahrung · doi:10.1002/food.19850290615 · Cited by 2
Current clinical laboratory practice: investigation of plasma lipids--which tests and when?
Marshall, W., & Ballantyne, F. C. (1986) · BMJ · doi:10.1136/bmj.292.6536.1652 · Cited by 2
Bae, J. H., Kim, K. B., Lee, H. J., Kim, K. S., Kim, Y. N., Lee, I. K., Huh, I. S., Yoon, J. S., Nam, C., Shin, W. S., et al. (1999) · Korean Circulation Journal · doi:10.4070/kcj.1999.29.7.680 · Cited by 2
Prevention and regression of atherosclerosis with drug therapy
Superko, H. R. (1991) · Clinical Cardiology · doi:10.1002/clc.4960141307 · Cited by 2
[Desogestrel contraceptives: the perfect pill for lipids?].
Laurendeau, L. (1996) · PubMed Central · Cited by 2
[Study of the prevalence of hypercholesterolemia in Extremadura].
Ortiz, A. G., Romano, R. J., Domínguez, J. A. V., & Rueda Muñoz, C. (1993) · PubMed · Cited by 2
Physicians' Attitudes to the Treatment of Elevated Serum Cholesterol
McDermid, G., Lang, C. C., Doran, J. F., & Struthers, A. D. (1990) · Journal of the Royal College of Physicians of London · doi:10.1016/s0035-8819(25)02056-2 · Cited by 2
Management of the hyperlipidaemias.
Jowett, N., & Galton, D. (1980) · Drug and therapeutics bulletin · doi:10.1007/978-1-4899-3294-5_12 · Cited by 2
Conceptual and Moral Problems of Genetic and Non-Genetic Preventive Interventions
Han, P. K. J. (2002) · Philosophy and medicine · doi:10.1007/978-94-010-0269-1_13 · Cited by 2
Hypertriglyceridemia (> 150 mg/dL) as a marker of cardiovascular risk
López-Miranda, J. (2025) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2025.500822 · Cited by 1
Coronary Heart Disease and Related Diseases
Dhawan, J. (2004) · Springer eBooks · doi:10.1007/978-1-4020-2231-9_22 · Cited by 1
Nonfasting serum triglycerides and risk of ischemic heart disease among Japanese men and women
Iso, H., Kitamura, A., Sato, S., Naito, Y., Imano, N., Ohira, T., Yamagishi, K., Tanigawa, T., & Shimamoto, T. (2004) · International Congress Series · doi:10.1016/j.ics.2004.01.014 · Cited by 1
Perfíl lipídico en una comunidad de Calarcá, Colombia
Arias, A., Castillo, M., Landázuri, P., Restrepo, B., & Betancourth, M. L. G. (1997) · Biomédica · doi:10.7705/biomedica.v17i3.952 · Cited by 1
Biochemical Changes among Workers Occupationally Exposed to Vibration.
Kf, E.-S., El-Gazzar, R., Mansour, H. A., & Hk, A. E.-G. (2009) · PubMed · Cited by 1
Lipids in Coronary Heart Disease
Martin, S. S., Joshi, P. H., & Michos, E. D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802385-3.00007-3 · Cited by 2
Dietary Components and the Risk of Coronary Heart Disease Mortality
Kromhout, D. (1985) · Springer eBooks · doi:10.1007/978-1-4684-7929-4_8 · Cited by 1
Risk Factors for Atherosclerosis: A Clinician’s Pragmatic Appraisal
Capron, L. (1989) · Springer eBooks · doi:10.1007/978-1-4471-1464-2_20 · Cited by 1
Flow cytometric quantification of cholesteryl ester-containing “foam” cells
Cupp, J. E., Campbell, G., Khan, M. A., & Kruth, H. S. (1987) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(87)90029-3 · Cited by 1
Zhang, L. (2010) · Työväentutkimus Vuosikirja · Cited by 1
Lipid disorders and their changes in postsocialist Estonia
Volozh, O., Abina, J., Деев, А. Д., Goldsteine, G., Kalyuste, T., Kaup, R., Olferiev, A., & SOLODKAYA, E. (1999) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 1
Grundy, S. M. (1991) · Postgraduate Medicine · doi:10.1080/00325481.1991.11701084 · Cited by 1
Prevalence of Hyperlipidaemia in British Compared with North American Men
Thompson, G. R., Robinson, D., Allaway, S. L., Bevan, E. A., & Ritchie, C. D. (1987) · Springer eBooks · doi:10.1007/978-3-642-71753-6_14 · Cited by 1
Effect of insulin on serum lipids in relation to nutritional status in diabetics
Das, G. P., Mandal, B., Ghosh, P., & Maity, C. R. (1993) · Indian Journal of Clinical Biochemistry · doi:10.1007/bf02867722 · Cited by 1
Management of Diabetic Dyslipidaemia
Betteridge, D. J. (2007) · Springer eBooks · doi:10.1007/978-0-387-69737-6_16 · Cited by 1
Hallfrisch, J., Ra, L., Michaelis, O. E., & Reiser, S. (1983) · Journal of the American College of Nutrition · doi:10.1080/07315724.1983.10719919 · Cited by 1
Effects of oral contraceptive pills on serum lipoproteins and triglycerides
Towobola, O. A. P., Otubu, J. A. M., & Uguru, V. E. (1990) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(90)90011-9 · Cited by 1
Metadata
- Authors
- Hulley, S. B., Rosenman, R. H., Bawol, R. D., & Brand, R. J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1980-06-19
- Volume
- 302
- Issue
- 25
- Pages
- 1383-1389
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1989258056
- Cited by
- 702
- References
- 88
- Citations by year
- 2025: 4 · 2024: 1 · 2023: 3 · 2022: 2 · 2021: 7 · 2020: 4 · 2019: 5 · 2018: 5 · 2017: 4 · 2016: 7 · 2015: 9 · 2014: 8 · 2013: 7 · 2012: 11
- FWCI
- 53.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- DigitalGeorgetown (Georgetown University Library) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- triglycerides, coronary artery disease, hypertriglyceridemia, causal inference, cholesterol, preventive medicine, burden of proof, screening, lipid-lowering therapy, clinical decision-making
- MeSH terms
- Adult, Cholesterol, Coronary Disease, Decision Making, Epidemiologic Methods, Ethics, Medical, Health Policy, Humans, Middle Aged, Retrospective Studies, Risk, Triglycerides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review